Hi Welcome You can highlight texts in any article and it becomes audio news that you can hear
  • Tue. Nov 5th, 2024

Malaria drug touted by Trump fails to prevent COVID-19 in high profile study

Byindianadmin

Jun 4, 2020 #Covid-, #Profile
Malaria drug touted by Trump fails to prevent COVID-19 in high profile study

(Reuters) – The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday.

FILE PHOTO: The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed at the Rock Canyon Pharmacy in Provo, Utah, U.S. May 27, 2020. REUTERS/George Frey

The new trial found no serious side effects or heart problems from use of hydroxychloroquine.

Vocal support from Trump kicked off a heated debate and raised expectations for the decades-old drug that could be a cheap and widely available tool in fighting the pandemic that has infected more than 6.4 million people and killed over 382,000 worldwide

In the first major study comparing hydroxychloroquine to a placebo to gauge its effect against the new coronavirus, University of Minnesota researchers tested 821 people who had recently been exposed to the virus or lived in a high-risk household.

It found 11.8% of subjects given hydroxychloroquine developed symptoms compatible with COVID-19, compared with 14.3%wh

Read More

Click to listen highlighted text!